Literature DB >> 29671652

Effects of Educated Monocytes with Xenogeneic Mesenchymal Stem Cell-Derived Conditioned Medium in a Mouse Model of Chronic Asthma.

Hadi Esmaili Gourvarchin Galeh1, Seyyed Meysam Abtahi Froushani1, Nahideh Afzale Ahangaran1, Siamak Naji Hadai2.   

Abstract

BACKGROUND: This study was conducted to determine the potential of the monocytes educated with rat bone marrow mesenchymal stem cell-derived conditioned medium (MCM) in ameliorating animal model of asthma.
METHODS: Chronic asthma was induced in the BALB/c mice using ovalbumin (OVA) sensitization. The monocytes were isolated from blood of mice and supplemented with 50% MCM or negative control media. After 24 h, the cells were designated as "non-educated or educated". Fourteen weeks after the onset of the study, animals were treated with educated or non-educated monocytes twice with a 1-week interval.
RESULTS: The educated monocytes showed a reduction in the potential production of the respiratory burst and nitric oxide and the secretion of IL-12 and IL-4 compared to non-educated monocytes. Conversely, these monocytes exhibited a significant increase in the production of IL-10 and TGF-?. Also, the levels of CD68+/CD206+ cells significantly increased in the population of educated monocytes. More importantly, the severity of histopathological lesions, NF-?B p65 mRNA level in lung tissues, total serum IgE and the total cell count, as well as the eosinophil count in the bronchoalveolar lavage fluid, were significantly decreased in OVA-inhaled mice treated with educated monocytes compared to OVA-sensitized group receiving non-educated monocytes. With no advantage in up-regulation of Foxp3 Treg cells, the treatment with educated monocytes reduced the secretion of IL-5 and IL-13 by splenocytes of asthma mice more than splenocytes of the asthma mice treated with non-educated monocytes.
CONCLUSION: The educated monocytes with MCM may be as a promising strategy for cell-based therapies of asthma.

Entities:  

Keywords:  Asthma; conditioned medium; mesenchymal stem cells; monocyte therapy

Mesh:

Substances:

Year:  2018        PMID: 29671652     DOI: 10.1080/08820139.2018.1458108

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  3 in total

1.  Non-Adherent Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Clinical Manifestations and Inflammation in an Experimental Model of Ulcerative Colitis in Rats.

Authors:  Siavash Mashhouri; Seyyed Meysam Abtahi Froushani; Ali Asghar Tehrani
Journal:  Iran J Med Sci       Date:  2020-09

2.  Evaluation of the protective and therapeutic effects of Pistacia atlantica gum aqueous extract on cellular and pathological aspects of experimental asthma in Balb/c mice.

Authors:  Zaynab Shakarami; Hadi Esmaeili Gouvrchin Ghaleh; Bahman Mansouri Motlagh; Ali Sheikhian; Bahman Jalali Kondori
Journal:  Avicenna J Phytomed       Date:  2019 May-Jun

3.  Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccine.

Authors:  Majdedin Ghalavand; Mojtaba Saadati; Jafar Salimian; Ebrahim Abbasi; Ghader Hosseinzadeh; Hadi Esmaeili Gouvarchin Ghaleh; Ali Ahmadi
Journal:  Clin Exp Vaccine Res       Date:  2021-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.